GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ArthroCare Corp (FRA:BQK) » Definitions » Cyclically Adjusted FCF per Share

ArthroCare (FRA:BQK) Cyclically Adjusted FCF per Share : €0.00 (As of Mar. 2014)


View and export this data going back to . Start your Free Trial

What is ArthroCare Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

ArthroCare's adjusted free cash flow per share for the three months ended in Mar. 2014 was €-0.584. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.00 for the trailing ten years ended in Mar. 2014.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-05-12), ArthroCare's current stock price is €35.05. ArthroCare's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2014 was €0.00. ArthroCare's Cyclically Adjusted Price-to-FCF of today is .


ArthroCare Cyclically Adjusted FCF per Share Historical Data

The historical data trend for ArthroCare's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArthroCare Cyclically Adjusted FCF per Share Chart

ArthroCare Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ArthroCare Quarterly Data
Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ArthroCare's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, ArthroCare's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArthroCare's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ArthroCare's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where ArthroCare's Cyclically Adjusted Price-to-FCF falls into.



ArthroCare Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ArthroCare's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2014 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2014 (Change)*Current CPI (Mar. 2014)
=-0.584/99.6945*99.6945
=-0.584

Current CPI (Mar. 2014) = 99.6945.

ArthroCare Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200406 -0.010 80.037 -0.012
200409 0.131 80.121 0.163
200412 0.025 80.290 0.031
200503 0.077 81.555 0.094
200506 0.124 82.062 0.151
200509 0.349 83.876 0.415
200512 0.189 83.032 0.227
200603 -0.037 84.298 -0.044
200606 0.242 85.606 0.282
200609 0.457 85.606 0.532
200612 0.077 85.142 0.090
200703 0.258 86.640 0.297
200706 0.333 87.906 0.378
200709 0.080 87.964 0.091
200712 0.163 88.616 0.183
200803 -0.004 90.090 -0.004
200806 0.362 92.320 0.391
200809 -0.065 92.307 -0.070
200812 -0.057 88.697 -0.064
200903 0.137 89.744 0.152
200906 0.246 91.003 0.269
200909 0.073 91.120 0.080
200912 -0.346 91.111 -0.379
201003 0.207 91.821 0.225
201006 0.533 91.962 0.578
201009 0.820 92.162 0.887
201012 0.429 92.474 0.462
201103 0.316 94.283 0.334
201106 0.639 95.235 0.669
201109 0.591 95.727 0.615
201112 0.295 95.213 0.309
201203 -1.582 96.783 -1.630
201206 0.578 96.819 0.595
201209 0.566 97.633 0.578
201212 0.351 96.871 0.361
201303 0.242 98.209 0.246
201306 0.719 98.518 0.728
201309 -0.208 98.790 -0.210
201312 0.119 98.326 0.121
201403 -0.584 99.695 -0.584

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


ArthroCare  (FRA:BQK) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


ArthroCare Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of ArthroCare's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


ArthroCare (FRA:BQK) Business Description

Traded in Other Exchanges
N/A
Address
ArthroCare was incorporated in California in 1993 and reincorporated in Delaware in 1995. The Company is a multi-business medical device Company that develops, manufactures and markets minimally invasive surgical products, many of which are based on its patented Coblation(r) technology. The Company has grown well beyond its roots in arthroscopy to capitalize on numerous market opportunities across several medical specialties, improving many existing soft-tissue surgical procedures and enabling new minimally invasive procedures. With its innovative technologies, the Company is improving the lives of individuals suffering from conditions as diverse as torn rotator cuffs and anterior cruciate ligaments to herniated discs and enlarged tonsils/tonsillitis. The Company currently markets minimally invasive surgical products across three core business units-ArthroCare Sports Medicine, which include shoulder and knee arthroscopic products; ArthroCare Spine, which include spinal and neurosurgery products; and ArthroCare Ear, Nose and Throat, which include ear, nose, throat and the Visage(r) cosmetic products; - but also has developed, manufactured and marketed Coblation-based and complementary products for application in neurology, cosmetic surgery, urology and gynecology, with research continuing in additional areas. In each of its core business units, the Company is focusing on driving the application of enabling technologies, primarily for plasma-based soft tissue removal, and increasing the number of minimally invasive procedures being performed. The Company is marketing and selling its arthroscopic/sports medicine, spinal surgery, ENT and cosmetic surgery products using a combination of distributors supported by regional sales mangers, a direct sales force and corporate partners to sell its products both domestically and internationally. The Company owns over 170 issued U.S. patents and over 195 issued international patents. The Company's products are considered medical devices and are subject to regulation in the United States, with the approval of FDA for each of its products. Its primary competitors include Medtronic, Inc., Smith & Nephew, Stryker Corporation, Johnson & Johnson, Olympus (through its subsidiary Gyrus) and Arthrex, Inc.

ArthroCare (FRA:BQK) Headlines

No Headlines